Paxos Labs Inc. — Form D
Paxos Labs Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-09. The offering totals $12.0M, of which $10.5M was reported sold. Industry: Other.
Offering
- Filed: 2026-01-09
- Form: D
- Accession: 0002097647-26-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $10.5M
- Remaining: $1.5M
- Investors: 43
- Date of first sale: 2025-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-569512
Issuer
- Name: Paxos Labs Inc.
- CIK: 0002097647
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 169 MADISON AVENUE, SUITE 38260, NEW YORK, NY, 10016
- Phone: (408) 673-7616
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Charles Cascarilla | Director | New York, NY |
| Bhaumik Kotecha | Director | New York, NY |
| Yuan Han Li | Director | New York, NY |
| Charles Cascarilla | Executive Officer | New York, NY |
| Bhaumik Kotecha | Executive Officer | New York, NY |
More